Quanterix: Ivana Magovčević-Liebisch
Quanterix has appointed Ivana Magovčević-Liebisch to its board of directors.
Magovčević-Liebisch is president and CEO of Vigil Neuroscience. Prior to that she was EVP and CBO at Ipsen. She was also SVP and head of global business development for the specialty drug business at Teva Pharmaceuticals as well as EVP and COO at Dyax.